Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05956964 · ClinicalTrials.gov registry record · NA
NM Balance Regulation With ULLS and Loss of Sleep
A NA study, sponsored by Lance Bollinger.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05956964: Completed NA study, sponsored by Lance Bollinger.
NCT05956964 is a NA study that has completed, run by Lance Bollinger. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05956964, a NA study, has completed, sponsored by Lance Bollinger.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goal of this trial is to learn about how restricted sleep and not bearing weight on the leg affects muscle strength and posture control. Participants will walk exclusively on one leg, sleep at differing intervals, and complete posture tests, muscle strength tests, and muscle imaging. Researchers will compare adequate sleep and restricted sleep to see if muscle strength and posture are affected.
Primary Outcome
Subjects will sit upright in an isokinetic dynamometer with the knee at 60° flexion. Gel electrode pads will be placed over the femoral nerve and just proximal to the patellar tendon. Square wave, constant current, doublet pulses from an electrical stimulator will be used to evoke twitches prior to, during, and following a maximal voluntary isometric contraction (MVIC). Twitch torque will be measured in Newton-meters (Nm). Outcome data are reported as the percentage change in voluntary activatio
Interventions
- BEHAVIORAL Sleep Restriction
- BEHAVIORAL Sleep Adequate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-08-10 |
| Est. Completion | 2025-03-14 |
| Phase | NA |
What the finished NCT05956964 record still lists
NCT05956964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Sleep Restriction is the first listed.
NCT05956964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05956964 about?
NCT05956964 is a clinical study titled "NM Balance Regulation With ULLS and Loss of Sleep". The goal of this trial is to learn about how restricted sleep and not bearing weight on the leg affects muscle strength and posture control. Participants will walk exclusively on one leg, sleep at differing intervals, and complete posture tests, muscle strength tests, and muscle imaging. Researchers...
What is the current status of trial NCT05956964?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2023-08-10. Estimated completion is 2025-03-14.
What interventions are being tested in trial NCT05956964?
The interventions under investigation include: Sleep Restriction (BEHAVIORAL), Sleep Adequate (BEHAVIORAL).
Who is sponsoring clinical trial NCT05956964?
This trial is sponsored by Lance Bollinger, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05956964's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI